GENETIC TECH (DU8.SG)
GENETIC TECH (DU8.SG) operates in Diversified Metals & Mining.
GENETIC TECH (DU8.SG) (DU8) - Total Assets
Latest total assets as of June 2024: €6.19 Million EUR
Based on the latest financial reports, GENETIC TECH (DU8.SG) (DU8) holds total assets worth €6.19 Million EUR as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
GENETIC TECH (DU8.SG) - Total Assets Trend (2016–2024)
This chart illustrates how GENETIC TECH (DU8.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
GENETIC TECH (DU8.SG) - Asset Composition Analysis
Current Asset Composition (June 2024)
GENETIC TECH (DU8.SG)'s total assets of €6.19 Million consist of 59.7% current assets and 40.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 16.5% |
| Accounts Receivable | €209.25K | 3.4% |
| Inventory | €206.47K | 3.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €360.06K | 5.8% |
| Goodwill | €1.78 Million | 28.9% |
Asset Composition Trend (2016–2024)
This chart illustrates how GENETIC TECH (DU8.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: GENETIC TECH (DU8.SG)'s current assets represent 59.7% of total assets in 2024, a decrease from 91.3% in 2016.
- Cash Position: Cash and equivalents constituted 16.5% of total assets in 2024, down from 84.1% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 33.0% of total assets, an increase from 4.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 28.9% of total assets.
GENETIC TECH (DU8.SG) Competitors by Total Assets
Key competitors of GENETIC TECH (DU8.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
GENETIC TECH (DU8.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - GENETIC TECH (DU8.SG) generates 1.24x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - GENETIC TECH (DU8.SG) is currently not profitable relative to its asset base.
GENETIC TECH (DU8.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.88 | 3.17 | 2.14 |
| Quick Ratio | 0.83 | 3.07 | 2.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-500.09K | € 7.19 Million | € 1.70 Million |
GENETIC TECH (DU8.SG) - Advanced Valuation Insights
This section examines the relationship between GENETIC TECH (DU8.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -58.4% |
| Total Assets | €6.19 Million |
| Market Capitalization | $271.39 USD |
Valuation Analysis
Below Book Valuation: The market values GENETIC TECH (DU8.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: GENETIC TECH (DU8.SG)'s assets decreased by 58.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for GENETIC TECH (DU8.SG) (2016–2024)
The table below shows the annual total assets of GENETIC TECH (DU8.SG) from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-06-30 | €6.19 Million | -58.36% |
| 2023-06-30 | €14.86 Million | -28.58% |
| 2022-06-30 | €20.80 Million | -9.45% |
| 2021-06-30 | €22.97 Million | +46.94% |
| 2020-06-30 | €15.63 Million | +378.80% |
| 2019-06-30 | €3.27 Million | -47.05% |
| 2018-06-30 | €6.17 Million | -49.08% |
| 2017-06-30 | €12.11 Million | -8.89% |
| 2016-06-30 | €13.29 Million | -- |